HealthStream (NASDAQ:HSTM) Stock: Insider Tate Deborah Taylor Sells 3,281 Shares

Posted by George Bondi on Nov 6th, 2026

HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) Director Deborah Tate sold 3,281 shares of the business’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $32.19, for a total transaction of $105,615.39. Following the sale, the director directly owned 21,418 shares in the company, valued at approximately $689,445.42. The trade was a 13.28% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

HealthStream Stock Down 2.4%

Shares of HSTM stock traded down $0.71 during mid-day trading on Friday, reaching $28.89. 249,732 shares of the stock traded hands, compared to its average volume of 254,352. The stock’s fifty day simple moving average is $31.20 and its two-hundred day simple moving average is $25.79. HealthStream, Inc. has a 1-year low of $19.50 and a 1-year high of $35.60. The company has a market cap of $844.02 million, a price-to-earnings ratio of 41.27, a price-to-earnings-growth ratio of 3.76 and a beta of 0.45.

HealthStream (NASDAQ:HSTM – Get Free Report) last posted its earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. The firm had revenue of $83.31 million for the quarter, compared to analyst estimates of $82.24 million. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. On average, equities research analysts anticipate that HealthStream, Inc. will post 0.72 EPS for the current fiscal year.

HealthStream Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Monday, November 16th will be given a dividend of $0.0350 per share. The ex-dividend date is Monday, November 16th. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. HealthStream’s dividend payout ratio is 20.00%.

Institutional Investors Weigh In On HealthStream

Hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new position in shares of HealthStream during the second quarter valued at about $111,184,000. Dimensional Fund Advisors LP boosted its stake in shares of HealthStream by 6.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares in the last quarter. Copeland Capital Management LLC lifted its stake in shares of HealthStream by 43.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of HealthStream by 0.5% during the 1st quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after buying an additional 2,380 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in shares of HealthStream by 21.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after purchasing an additional 65,806 shares in the last quarter. 69.58% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Freedom Capital upgraded HealthStream to a “hold” rating in a research note on Tuesday, October 13th. Weiss Ratings raised HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a research report on Tuesday, October 27th. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Finally, Canaccord Genuity Group lifted their price target on HealthStream from $29.00 to $32.00 and gave the company a “hold” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $36.00.

Check Out Our Latest Analysis on HSTM

HealthStream Company Profile

(Get Free Report)

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.